Ovid Therapeutics Stock Forward View - Price Action Indicator
| OVID Stock | USD 1.55 0.26 14.36% |
Ovid Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Ovid Therapeutics stock prices and determine the direction of Ovid Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Ovid Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time, the value of RSI of Ovid Therapeutics' share price is approaching 48. This indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Ovid Therapeutics, making its price go up or down. Momentum 48
Impartial
Oversold | Overbought |
Using Ovid Therapeutics hype-based prediction, you can estimate the value of Ovid Therapeutics from the perspective of Ovid Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
Ovid Therapeutics after-hype prediction price | USD 1.55 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Ovid Therapeutics to cross-verify your projections. For information on how to trade Ovid Stock refer to our How to Trade Ovid Stock guide.Ovid Therapeutics Additional Predictive Modules
Most predictive techniques to examine Ovid price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Ovid using various technical indicators. When you analyze Ovid charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Price Action Indicator | Price Action Indicator | Trend |
| (0.26) | (0.12) |
| Check Ovid Therapeutics Volatility | Backtest Ovid Therapeutics | Information Ratio |
Ovid Therapeutics Trading Date Momentum
| On January 29 2026 Ovid Therapeutics was traded for 1.55 at the closing time. The top price for the day was 1.59 and the lowest listed price was 1.50 . The trading volume for the day was 1.5 M. The trading history from January 29, 2026 did not cause price change. The trading delta at closing time against the current closing price is 0.00% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
| Compare Ovid Therapeutics to competition |
Other Forecasting Options for Ovid Therapeutics
For every potential investor in Ovid, whether a beginner or expert, Ovid Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Ovid Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Ovid. Basic forecasting techniques help filter out the noise by identifying Ovid Therapeutics' price trends.Ovid Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ovid Therapeutics stock to make a market-neutral strategy. Peer analysis of Ovid Therapeutics could also be used in its relative valuation, which is a method of valuing Ovid Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Ovid Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Ovid Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Ovid Therapeutics shares will generate the highest return on investment. By undertsting and applying Ovid Therapeutics stock market strength indicators, traders can identify Ovid Therapeutics entry and exit signals to maximize returns.
| Accumulation Distribution | 82987.19 | |||
| Daily Balance Of Power | (2.89) | |||
| Rate Of Daily Change | 0.86 | |||
| Day Median Price | 1.55 | |||
| Day Typical Price | 1.55 | |||
| Price Action Indicator | (0.12) | |||
| Period Momentum Indicator | (0.26) | |||
| Relative Strength Index | 48.49 |
Ovid Therapeutics Risk Indicators
The analysis of Ovid Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Ovid Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting ovid stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.22 | |||
| Semi Deviation | 4.86 | |||
| Standard Deviation | 6.04 | |||
| Variance | 36.42 | |||
| Downside Variance | 31.14 | |||
| Semi Variance | 23.66 | |||
| Expected Short fall | (5.50) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Ovid Therapeutics
The number of cover stories for Ovid Therapeutics depends on current market conditions and Ovid Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Ovid Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Ovid Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Ovid Therapeutics Short Properties
Ovid Therapeutics' future price predictability will typically decrease when Ovid Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Ovid Therapeutics often depends not only on the future outlook of the potential Ovid Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Ovid Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 70.9 M | |
| Cash And Short Term Investments | 53.1 M |
Check out Historical Fundamental Analysis of Ovid Therapeutics to cross-verify your projections. For information on how to trade Ovid Stock refer to our How to Trade Ovid Stock guide.You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Will Stock sector continue expanding? Could Ovid diversify its offerings? Factors like these will boost the valuation of Ovid Therapeutics. Anticipated expansion of Ovid directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Ovid Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Ovid Therapeutics's market price often diverges from its book value, the accounting figure shown on Ovid's balance sheet. Smart investors calculate Ovid Therapeutics' intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Ovid Therapeutics' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Ovid Therapeutics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Ovid Therapeutics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Ovid Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.